Phase II trial of AMSA in previously treated patients with stage III and IV ovarian cancer.
D000609:Aminoacridines / Q000008:administration & dosage / Q000627:therapeutic use*; D000677:Amsacrine; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007263:Infusions, Parenteral; D009362:Neoplasm Metastasis; D010051:Ovarian Neoplasms / Q000188:drug therapy*
D000609:Aminoacridines; D000970:Antineoplastic Agents; D000677:Amsacrine